Nutrition, Overgrowth, and Vaccine Efficacy in Low-income Settings
NCT02745327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270
Last updated 2019-05-15
Summary
The purpose of this study is to assess the impact of small intestine bacterial overgrowth (SIBO) on childhood nutritional status, growth, and oral vaccine efficacy.
Conditions
- Small Intestine Bacterial Overgrowth
Sponsors & Collaborators
-
Virginia Commonwealth University
collaborator OTHER -
International Centre for Diarrhoeal Disease Research, Bangladesh
collaborator OTHER -
University of Virginia
lead OTHER
Principal Investigators
-
William A Petri, M.D., PhD · University of Virginia
Eligibility
- Min Age
- 1 Day
- Max Age
- 7 Days
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Bangladesh
Study Locations
More Related Trials
-
The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan
NCT03031743 ·Status: COMPLETED
-
Oral Vaccination Against Clostridium Difficile Infection
NCT02991417 ·Status: TERMINATED ·Phase: PHASE1
-
Does the Fecal Microbiome Influence Rotarix Immunogenicity
NCT02220439 ·Status: COMPLETED
-
Primary Prophylaxis for Spontaneous Bacterial Peritonitis
NCT04775329 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
FMT for Moderate to Severe CDI: A Randomised Study With Concurrent Stool Microbiota Assessment
NCT02570477 ·Status: UNKNOWN ·Phase: NA
-
A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.
NCT02117570 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Response to C.Difficile Infection
NCT02797288 ·Status: UNKNOWN
-
Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.
NCT04910815 ·Status: RECRUITING ·Phase: NA
-
Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific Countries
NCT02223715 ·Status: COMPLETED
-
Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD Patients
NCT05770726 ·Status: RECRUITING ·Phase: NA
-
The Role of the Gut Microbiota in the Systemic Immune Response During Human Endotoxemia
NCT02127749 ·Status: COMPLETED ·Phase: NA
-
Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
NCT04244877 ·Status: WITHDRAWN ·Phase: PHASE3
-
Response of Clostridium Difficile Infection to Metronidazole Therapy
NCT00304369 ·Status: COMPLETED
-
Small Bowel Transit Time in Clostridium Difficile Colitis
NCT01309750 ·Status: TERMINATED
-
Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms
NCT06524791 ·Status: NOT_YET_RECRUITING
-
Study of Clostridioides Difficile in Infants
NCT06788769 ·Status: RECRUITING
-
Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.
NCT06772064 ·Status: RECRUITING ·Phase: NA
-
Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections
NCT02774382 ·Status: UNKNOWN ·Phase: PHASE3
-
Molecular Epidemiology of Clostridium Difficile Infections in Children
NCT01957761 ·Status: COMPLETED
-
Study on Clostridium Difficile Infection in Infants
NCT06703918 ·Status: RECRUITING
-
Building an AI to Infer/Predict an Estimated Stool Microbiome Profile
NCT05847543 ·Status: COMPLETED
-
Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity
NCT00772954 ·Status: TERMINATED ·Phase: PHASE1
-
Clostridium Difficile Infection: the First Report in Southeast Asia by 2010 Nationwide Study
NCT02327520 ·Status: COMPLETED
-
Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection
NCT00772343 ·Status: COMPLETED ·Phase: PHASE2
-
Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections
NCT03895593 ·Status: RECRUITING